Skip to search formSkip to main contentSkip to account menu

Drug Evaluation, FDA Phase IV as Topic

Known as: Drug Evaluation, FDA Phase 4 as Topic, Evaluation Studies, FDA Phase 4 as Topic, Evaluation Studies, FDA Phase IV as Topic 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Clinical Trials
Phase 4 Clinical Trials

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Community pharmacists' understanding and perceptions of FDA therapeutic equivalence standards
2015
2015
35 X-Stop interspinous systemsLumbar spineinterspinous process distraction (IPD) systemsX-StopInterspinous process distraction (IPD) systemsX-Stopclinical results forInterspinous process distraction…
2014
2014
Topic clause identification method based on specific features
When identifying the Topic Clause(TC) of Punctuation Clause(PClause),the brute-force method to generate Candidate Topic Clause… 
Review
2013
Review
2013
Validation of an Evidence-Based Medicine Critically Appraised Topic Presentation Evaluation Tool (EBM C-PET).
BACKGROUND Competence in evidence-based medicine (EBM) is an important clinical skill. Pediatrics residents are expected to… 
2013
2013
Information about the Critically Appraised Topic (cat) Series
The objective of the Doctor of Nursing Practice (DNP) program at George Mason University is to prepare graduates for the highest… 
2010
2010
An Adaptive Topic Tracking Model Based on 3-Dimension Document Vector
Topic Tracking(TT),which grows out of the Topic Detection and Tracking(TDT) tasks,is a technology of information intelligent… 
2006
2006
Learning evidence-based veterinary medicine through development of a critically appraised topic.
Evidence-based veterinary medicine is a relatively new field of study. Increased knowledge of medicine coupled with the increased… 
2006
2006
[Off-label use in oncology: an inexhaustible topic?!].
In 2002, with its "Off-label verdict", the German Federal Social Court (Bundessozialgericht; BSG) issued a fundamental decision… 
2001
2001
Psiconáutica católica: Alles, Alexander Shulgin y Ann Sulgin, la DEA y la FDA
1999
1999
Immunogenicity of FDA DTP versus WHO DTP.
BACKGROUND The aim of this report was to study the immunogenicity of three doses of DTP in six-week-old Saudi infants when given… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)